IL1A and chronic kidney disease: In summary, we report that IL-1 antagonism and specific pharmacological blockade using the IL-1 receptor antagonist, anakinra, attenuates muscle wasting and adipose tissue browning in CKD mice via multiple cellular mechanisms (Fig. 9).